OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Publication Date
Release Date
2024
(4)
2019
(4)
2023
(3)
2021
(2)
2025
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Prevalence of symptoms in children with acute lymphoblastic leukaemia: a systematic review and meta-analysis.
Not available
S-EPMC10648628
|
biostudies-literature
Cite
Development and experimental validation of computational methods for human antibody affinity enhancement.
Not available
S-EPMC11446602
|
biostudies-literature
Cite
An association between elevated telomerase reverse transcriptase expression and the immune tolerance disruption of dendritic cells.
Not available
S-EPMC11112790
|
biostudies-literature
Cite
Study on RNAi-based herbicide for Mikania micrantha.
Not available
S-EPMC8637008
|
biostudies-literature
Cite
Identification of Piezo1 as a potential target for therapy of colon cancer stem-like cells.
Not available
S-EPMC10260724
|
biostudies-literature
Cite
Isomerization enabling near-infrared electron acceptors.
Not available
S-EPMC9075510
|
biostudies-literature
Cite
MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer.
Not available
S-EPMC8433071
|
biostudies-literature
Cite
A New Wide Bandgap Donor Polymer for Efficient Nonfullerene Organic Solar Cells with a Large Open-Circuit Voltage.
Not available
S-EPMC6839623
|
biostudies-literature
Cite
Secondary Bile Acids Modified by Odoribacter Splanchnicus Alleviate Colitis by Suppressing Neutrophil Extracellular Trap Formation.
Not available
S-EPMC12697870
|
biostudies-literature
Cite
An improved Tet-on system in microRNA overexpression and CRISPR/Cas9-mediated gene editing.
Not available
S-EPMC6556963
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets